The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...

Dental flossing is associated with a lower risk for ischemic and cardioembolic stroke and atrial fibrillation (AF), according ...

Discover how abelacimab reduces bleeding risks in AFib patients by effectively lowering free factor XI levels.

Flossing at least once a week may lower the risk of stroke and atrial fibrillation, according to preliminary results from a ...

People who floss their teeth at least once a week are reducing their risk of stroke caused by a blood clot, researchers are ...

Researchers have found in a new research that among patients with atrial fibrillation who are at moderate-to-high risk for ...

The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...

Cognitive performance may be improved and inflammatory markers may be reduced in older patients with atrial fibrillation who regularly consume coffee.